Hypothyroidism and low T3 reduce insulin sensitivity and alter glucose metabolism.

The relationship between thyroid function and glucose metabolism is complex, as thyroid hormones serve as primary regulators of metabolic flux. Hypothyroidism and low triiodothyronine (T3) signaling are consistently associated with systemic insulin resistance and significant alterations in how the body produces and utilizes glucose.

Clinical evidence and insulin sensitivity

Research consistently demonstrates that both overt and subclinical hypothyroidism (SCH) are linked to reduced insulin sensitivity.

• Insulin Resistance Markers: Individuals with SCH frequently exhibit elevated Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) values and higher fasting insulin levels compared to euthyroid controls. TSH levels have been shown to positively correlate with these markers of resistance (p < 0.05 in multiple cohorts).
• T3 Specificity: Low free T3 levels are independently associated with higher HOMA-IR, even in non-diabetic populations, suggesting that peripheral thyroid hormone action is a critical determinant of glucose disposal.
• Treatment Limitations: Interestingly, while levothyroxine (T4) replacement can normalize TSH, it does not always fully reverse insulin resistance, highlighting the importance of intracellular T3 availability.

Mechanistic explanations

The disruption of glucose homeostasis in low T3 states occurs through several distinct molecular and neural pathways:

• Cellular Signaling: Low T3 impairs the crosstalk between thyroid hormone receptors (TR) and the insulin-responsive PI3K/AKT cascade. Furthermore, elevated TSH can trigger endoplasmic reticulum (ER) stress via the IRE1α/XBP-1 and JNK pathways in hepatocytes and adipocytes, directly interfering with insulin signal transduction.
• Peripheral Glucose Uptake: T3 is essential for the expression and translocation of the glucose transporter GLUT4 in skeletal muscle and white adipose tissue. Reduced T3 signaling leads to decreased GLUT4 density on cell membranes, significantly lowering peripheral glucose disposal rates (Rd).
• Hepatic Glucose Production (HGP): T3 regulates HGP through direct binding to hepatic TRβ, which suppresses gluconeogenic genes and modulates intestinal GLP-1 production. Additionally, T3 influences HGP via a sympathetic neural pathway originating in the hypothalamus. In hypothyroid states, this regulatory axis is disrupted, often leading to a "hypo-metabolic" state with reduced but dysregulated gluconeogenesis and increased hepatic fat accumulation.

Bottom line

Hypothyroidism and low T3 signaling are strongly associated with reduced insulin sensitivity and altered glucose flux. This occurs through impaired GLUT4-mediated peripheral uptake, disrupted hepatic gene regulation, and systemic ER stress, collectively increasing the risk for metabolic dysfunction.